Michael Castagna

Michael Castagna

Algemeen Directeur bij MANNKIND CORPORATION

Vermogen: 9 M $ op 31-05-2026

49 jaar
Health Technology
Consumer Services
Process Industries

Profiel

Michael E.
Castagna
is Chief Executive Officer & Director at MannKind Corp.
since 2017, President, Chief Executive Officer & Director at scPharmaceuticals, Inc. starting in 2025, and Director at Pet Partners.
Former roles include Executive Director-Immunology Franchise at Bristol Myers Squibb Co. from 2010 to 2012, Director at Pharmasset, Inc. from 2005 to 2006, Vice President-Global Commercial at Amgen, Inc. from 2012 to 2016, Vice President & Head-Biopharmaceuticals at Sandoz, Inc. from 2009 to 2010, and VP & Head-North America Biopharmaceuticals at Novartis AG.
Education includes a doctorate from Massachusetts College of Pharmacy & Health Science in 2014, an MBA from The Wharton School of the University of Pennsylvania in 2005, and an undergraduate degree from Philadelphia College of Pharmacy in 2000.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
11-05-2026 2.442.310 ( 0,79% ) 9 M $ 31-05-2026

Actieve functies van Michael Castagna

BedrijvenFunctieBegin
MANNKIND CORPORATION Algemeen Directeur 25-05-2017
SCPHARMACEUTICALS INC. Algemeen Directeur 07-10-2025
Directeur/Bestuurslid -

Eerdere bekende functies van Michael Castagna

BedrijvenFunctieEinde
AMGEN INC. Corporate Officer/Principal 14-03-2016
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01-11-2012
Corporate Officer/Principal 01-11-2010
Directeur/Bestuurslid -
NOVARTIS AG Corporate Officer/Principal -
Ervaring van Michael Castagna in detail bekijken

Opleiding van Michael Castagna

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

75

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Process Industries

  1. Beurs
  2. Insiders
  3. Michael Castagna